Definity Raises $7M in Series A to Expand Healthcare Workforce Platform
Every hospital runs on a fragile equation. Demand spikes, staffing lags, and somewhere between scheduling grids and budget sheets, margins start sweating. Labor drives more than half the cost structure, yet most systems are still managing it like a puzzle with missing pieces. Definity stepped into that gap with something built less like software and more like infrastructure for reality.
Now they just locked in $7M in Series A funding, led by Accrete Health Partners, the digital venture arm of Bon Secours Mercy Health. Not tourist capital. Operator capital. The kind that shows up with opinions, data, and a very real expectation that this thing works at scale. Additional investors joined the round, names tucked away, but the signal is loud enough.
Kris Cannon has been steering this as President, and you can feel the intent in the product. This is not another patchwork tool pretending to be a system. Definity consolidates what used to be nine separate workflows into one rhythm. Vendor management, applicant tracking, gig staffing, real time analytics. All living in the same place, finally talking to each other like adults in the room.
And then there is Bon Secours Mercy Health stepping in as both investor and customer. 60,000 associates. 1,200+ care sites. 47 hospitals. That is not a pilot. That is a proving ground. Allan Calonge joining the board tightens the loop between what hospitals need and what Definity builds next. No guessing. Just feedback at enterprise scale.
The play here is subtle but sharp. Vendor neutral means no baked in bias. Real time visibility means fewer surprises. Internal mobility means less reliance on expensive external agencies. When labor is your biggest line item, shaving inefficiency is not optimization, it is survival with better margins.
Healthcare does not need more noise. It needs systems that understand pressure. Definity is leaning into that pressure, turning it into structure, and getting paid to do it. That is how you earn a Series A that actually means something in a market that is tired of promises and very interested in outcomes.









